Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Definitive Healthcare Launches Powerful Consumer Analytics and Activation Solution to More Industries With Population Intelligence Expansion
Several Reasons Led Conestoga Capital Advisors to Sell Definitive Healthcare Corp. (DH)
Express News | Deutsche Bank Maintains Hold on Definitive Healthcare, Lowers Price Target to $5
Analysts Have Been Trimming Their Definitive Healthcare Corp. (NASDAQ:DH) Price Target After Its Latest Report
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Express News | Baird Maintains Neutral on Definitive Healthcare, Lowers Price Target to $5
Definitive Healthcare Second Quarter 2024 Earnings: EPS Misses Expectations
Barclays Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $4
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), Definitive Healthcare Corp (DH) and Bicycle Therapeutics (BCYC)
Goldman Sachs Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $4
Definitive Healthcare Is Maintained at Equal-Weight by Morgan Stanley
Some Definitive Healthcare Corp. (NASDAQ:DH) Shareholders Look For Exit As Shares Take 34% Pounding
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $4 to $7.5
Express News | Definitive Healthcare : Morgan Stanley Cuts Target Price to $5.00 From $9.00
Definitive Healthcare Corp: A Balanced Hold Amidst Revenue Forecast Cuts and Strategic Uncertainties
Stifel Nicolaus Reaffirms Their Buy Rating on Definitive Healthcare Corp (DH)
Needham Reiterates Hold on Definitive Healthcare
Definitive Healthcare Analyst Ratings
Express News | Definitive Healthcare Sees Q3 2024 Revenue $61M-$62.5M Vs $63.16M Estimate
No Data
No Data